2020 Revenues ($USD) : $6,514,525,192
2020 Revenues (foreign currencies) : JP¥695,621,000,000
2020 R&D spend : $1,312,193,2945
2020 Number of Employees : 10,998
Fiscal Year End : 3/31/2020
Key People : Haruo Naito, CEO

Formed from the merger of two labs in 1944, Esai now boasts a global network of R&D facilities, manufacturing sites and marketing subsidiaries, including its Eisai Center for Genetics Guided Dementia Discovery (G2D2) that fully opened in Cambridge, Mass. in 2019. The company has a particular focus on neurology and oncology. –CN